FDA

Study will focus on effects of CBD and CBG for canine elbow osteoarthritis

Funding intended to improve the animal food ingredient review and approval process as well as developing regulations for ingredient claims

Dechra’s alpha-2 combination drug is indicated to minimize stress surrounding canine sedation

This chewable tablet is the first drug on the market for delaying the onset of Stage B2 preclinical myxomatous mitral valve disease in canines

Pharmaceutical sponsors who meet the eligibility requirements or their research partners are encouraged to apply.

Tulathromycin injection is an option for bovine respiratory disease, and other conditions